Skip to main content
. Author manuscript; available in PMC: 2013 Jul 31.
Published in final edited form as: J Alzheimers Dis. 2012;31(2):265–275. doi: 10.3233/JAD-2012-111922

Table 3.

Model* results for progression for individuals with normal cognition or MCI at baseline

Always depressed versus never depressed**
p-value
Rate Ratio (95% CI)
From Normal at Baseline to MCI***
 Always depressed during follow-up 2.35 1.86 2.96 <0.0001
 Depressed at 1st visit but later not depressed 1.41 1.01 1.95 0.04
 Intermittent depression over follow-up 2.22 1.86 2.65 <0.0001
 Prior history of depression 1.00 0.81 1.23 0.99
Antidepressant****
 SSRI 1.22 0.98 1.51 0.08
 Non-selective/Other 1.17 0.93 1.48 0.17
From MCI at baseline to AD***
 Always depressed during follow-up 1.21 1.00 1.46 0.06
 Depressed after 1st visit but later not depressed 0.86 0.64 1.16 0.33
 Intermittent depression over follow-up 1.15 0.97 1.37 0.11
 Prior history of depression 0.96 1.04 0.89 0.66
Antidepressant****
 SSRI 1.38 1.17 1.63 0.0001
 Non-selective/other 1.25 1.03 1.52 0.02
*

All models adjusted for age, gender, race, education, history of stroke/transient ischemic attack (TIA), history of diabetes, four cognitive tests (MMSE, logical memory, category fluency, WAIS), and functional activity (FAQ). Data for missing values imputed.

**

depression defined as either current or in the last 2 years.

***

5,607 (883 transitioned) individuals in analysis from normal to worse, 2,500 (856 transitioned) individuals in analysis from MCI to AD.

****

Drugs are time-dependent, considered at time of failure of each index case.